RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.
Cost-effectiveness of community-based interventions for reducing opioid overdose and non-overdose deaths
simulation modeling of HEALing communities study
Chhatwal, J., Sahinkoc, M., Chen, Q., Dowd, W., Xiao, J., Zarkin, G. A., Aldridge, A., Barocas, J. A., Cerdá, M., Fareed, N., Frazier, L. A., Hyder, A., Keyes, K. M., Knott, C. E., LaRochelle, M., Linas, B. P., Oga, E., Roberts, S. M., Samet, J. H., ... Barbosa, C. (2026). Cost-effectiveness of community-based interventions for reducing opioid overdose and non-overdose deaths: simulation modeling of HEALing communities study. Lancet regional health. Americas, 59, 101480. https://doi.org/10.1016/j.lana.2026.101480
BACKGROUND: The opioid overdose crisis remains a public health emergency in the United States. Evidence-based practices-including medications for opioid use disorder (MOUD) and naloxone distribution-can reduce harms, but their community-level cost-effectiveness is uncertain and may vary locally. We aimed to evaluate the cost-effectiveness of enhanced community-level implementation of evidence-based practices for opioid use disorder (OUD).
METHODS: We used a validated microsimulation model of OUD, calibrated with data from the HEALing Communities Study across 26 highly impacted communities in Massachusetts, New York, and Ohio. Six intervention scenarios for 2025-2030: maintaining 2024 evidence-based practice levels (status quo); improved naloxone distribution; improved MOUD retention; improved MOUD initiation; combined initiation and retention; and combined initiation, retention, and naloxone distribution. Outcomes included opioid overdose deaths (OODs), non-overdose opioid-related deaths, quality-adjusted life years (QALYs), costs (healthcare and societal), and incremental cost-effectiveness ratios (ICERs).
FINDINGS: Maintaining 2024 evidence-based practice levels was projected to yield OODs of 39-468 per 100,000 and non-overdose deaths of 238-3018 per 100,000 across communities. Enhancing MOUD initiation, retention, and naloxone distribution reduced OODs by 15-40% and non-overdose deaths by 7-24%, producing the largest QALY gains (1006-38,292). From the healthcare perspective, improved initiation plus retention was cost-effective in all communities (ICER US$11,765-US$91,058 per QALY); from the societal perspective, all enhanced scenarios were cost-saving (US$121 million-US$4.74 billion net savings).
INTERPRETATION: Community-level enhancement of MOUD initiation and retention, and for some communities also enhancing naloxone distribution, can substantially reduce opioid-related-overdose and non-overdose-deaths. These strategies are cost-effective from a healthcare perspective and cost-saving from a societal perspective, supporting investment in comprehensive, community-tailored interventions.
RTI shares its evidence-based research - through peer-reviewed publications and media - to ensure that it is accessible for others to build on, in line with our mission and scientific standards.